AU2019375975B2 - Artificial expression constructs for selectively modulating gene expression in excitatory cortical neurons - Google Patents
Artificial expression constructs for selectively modulating gene expression in excitatory cortical neurons Download PDFInfo
- Publication number
- AU2019375975B2 AU2019375975B2 AU2019375975A AU2019375975A AU2019375975B2 AU 2019375975 B2 AU2019375975 B2 AU 2019375975B2 AU 2019375975 A AU2019375975 A AU 2019375975A AU 2019375975 A AU2019375975 A AU 2019375975A AU 2019375975 B2 AU2019375975 B2 AU 2019375975B2
- Authority
- AU
- Australia
- Prior art keywords
- seq
- sequence
- expression
- cells
- artificial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0393—Animal model comprising a reporter system for screening tests
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Environmental Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2025242185A AU2025242185A1 (en) | 2018-11-05 | 2025-10-02 | Artificial expression constructs for selectively modulating gene expression in excitatory cortical neurons |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862755988P | 2018-11-05 | 2018-11-05 | |
| US62/755,988 | 2018-11-05 | ||
| US201962806600P | 2019-02-15 | 2019-02-15 | |
| US201962806684P | 2019-02-15 | 2019-02-15 | |
| US62/806,600 | 2019-02-15 | ||
| US62/806,684 | 2019-02-15 | ||
| US201962872021P | 2019-07-09 | 2019-07-09 | |
| US62/872,021 | 2019-07-09 | ||
| PCT/US2019/059927 WO2020097121A1 (en) | 2018-11-05 | 2019-11-05 | Artificial expression constructs for selectively modulating gene expression in excitatory cortical neurons |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2025242185A Division AU2025242185A1 (en) | 2018-11-05 | 2025-10-02 | Artificial expression constructs for selectively modulating gene expression in excitatory cortical neurons |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2019375975A1 AU2019375975A1 (en) | 2021-06-17 |
| AU2019375975B2 true AU2019375975B2 (en) | 2025-07-10 |
Family
ID=70612483
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2019375975A Active AU2019375975B2 (en) | 2018-11-05 | 2019-11-05 | Artificial expression constructs for selectively modulating gene expression in excitatory cortical neurons |
| AU2025242185A Pending AU2025242185A1 (en) | 2018-11-05 | 2025-10-02 | Artificial expression constructs for selectively modulating gene expression in excitatory cortical neurons |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2025242185A Pending AU2025242185A1 (en) | 2018-11-05 | 2025-10-02 | Artificial expression constructs for selectively modulating gene expression in excitatory cortical neurons |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20210395780A1 (https=) |
| EP (1) | EP3877529A4 (https=) |
| JP (3) | JP7590962B2 (https=) |
| AU (2) | AU2019375975B2 (https=) |
| CA (1) | CA3118689A1 (https=) |
| WO (1) | WO2020097121A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3923995A4 (en) * | 2019-02-15 | 2023-05-17 | Allen Institute | ARTIFICIAL EXPRESSION RECOMBINANTS FOR THE SELECTIVE MODULATION OF GENE EXPRESSION IN SELECTED NEURON CELL POPULATIONS |
| JP7624728B2 (ja) | 2019-02-25 | 2025-01-31 | ユニバーシティ オブ マサチューセッツ | Dna結合ドメイントランスアクチベーター及びその使用 |
| EP4162041A4 (en) * | 2020-06-04 | 2024-10-16 | Allen Institute | ARTIFICIAL EXPRESSION CONSTRUCTS TO SELECTIVELY MODULATE GENE EXPRESSION IN INHIBITORY NEOCORTICAL NEURONS |
| WO2022020706A1 (en) * | 2020-07-24 | 2022-01-27 | University Of Massachusetts | Dna-binding domain transactivators and uses thereof |
| WO2022036255A1 (en) * | 2020-08-14 | 2022-02-17 | Allen Institute | Artificial expression constructs for modulating gene expression in striatal neurons |
| GB202013940D0 (en) | 2020-09-04 | 2020-10-21 | Synpromics Ltd | Regulatory nucleic acid sequences |
| EP4244366A4 (en) * | 2020-11-10 | 2024-12-25 | Allen Institute | Artificial expression constructs for modulating gene expression in chandelier cells |
| WO2022155358A1 (en) * | 2021-01-13 | 2022-07-21 | Duke University | Compositions for and methods of improving fluid flux in the brain |
| US20240182923A1 (en) * | 2021-03-30 | 2024-06-06 | Allen Institute | Artificial expression constructs for modulating gene expression in claustrum neurons |
| US20240254514A1 (en) * | 2021-05-21 | 2024-08-01 | Allen Institute | Artificial expression constructs for modulating gene expression in neurons within the thalamus |
| CN113736734B (zh) * | 2021-09-23 | 2022-10-25 | 中山大学中山眼科中心 | 一种用于灵长类动物神经元分离的试剂盒及方法 |
| WO2023108021A1 (en) * | 2021-12-07 | 2023-06-15 | Allen Institute | Artificial expression constructs for modulating gene expression in neocortical layer 4 or layer 5 intratelencephalic neurons |
| US20250163458A1 (en) * | 2022-02-24 | 2025-05-22 | Allen Institute | Artificial expression constructs for modulating gene expression in dopaminergic neurons |
| CN114752624B (zh) * | 2022-04-08 | 2025-04-15 | 中国海洋大学 | 一种侏儒蛤卵子的电穿孔方法 |
| WO2024011224A2 (en) * | 2022-07-08 | 2024-01-11 | The Trustees Of Columbia University In The City Of New York | Regulatory element for cell type specific expression of genes in spinal motor neurons |
| WO2024238448A2 (en) * | 2023-05-12 | 2024-11-21 | Temple University - Of The Commonwealth System Of Higher Education | Chimeric capsid recombinant adeno-associated virus with bbb penetration and microglia targeting (aav-bm) |
| CN117346715B (zh) * | 2023-12-04 | 2024-03-08 | 成都深瑞同华科技有限公司 | 一种配电网架空线路弧垂测定方法、系统及存储介质 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170360961A1 (en) * | 2014-12-30 | 2017-12-21 | Universidad De Chile | Aav/xbp1s-ha virus, gene therapy method and use thereof in the optimisation and improvement of learning, memory and cognitive capacities |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2028268A1 (en) * | 2007-08-20 | 2009-02-25 | Université Libre De Bruxelles | Generation of neuronal cells from pluripotent stem cells |
| WO2014080381A1 (en) * | 2012-11-26 | 2014-05-30 | Ecole Polytechnique Federale De Lausanne (Epfl) | Colorectal cancer classification with differential prognosis and personalized therapeutic responses |
| EA201992358A1 (ru) * | 2017-04-03 | 2020-03-24 | Инкоудид Терапьютикс, Инк. | Тканеселективная экспрессия трансгена |
-
2019
- 2019-11-05 US US17/291,584 patent/US20210395780A1/en active Pending
- 2019-11-05 WO PCT/US2019/059927 patent/WO2020097121A1/en not_active Ceased
- 2019-11-05 JP JP2021523074A patent/JP7590962B2/ja active Active
- 2019-11-05 AU AU2019375975A patent/AU2019375975B2/en active Active
- 2019-11-05 EP EP19881101.0A patent/EP3877529A4/en active Pending
- 2019-11-05 CA CA3118689A patent/CA3118689A1/en active Pending
-
2024
- 2024-11-14 JP JP2024198841A patent/JP7774695B2/ja active Active
- 2024-12-31 US US19/007,263 patent/US20250236886A1/en active Pending
-
2025
- 2025-10-02 AU AU2025242185A patent/AU2025242185A1/en active Pending
- 2025-10-17 JP JP2025175276A patent/JP2026021360A/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170360961A1 (en) * | 2014-12-30 | 2017-12-21 | Universidad De Chile | Aav/xbp1s-ha virus, gene therapy method and use thereof in the optimisation and improvement of learning, memory and cognitive capacities |
Non-Patent Citations (1)
| Title |
|---|
| MO ALISA ET AL: "Epigenomic Signatures of Neuronal Diversity in the Mammalian Brain", NEURON, vol. 86, no. 6, 17 June 2015 (2015-06-17), pages 1369 - 1384, XP029215120, ISSN: 0896-6273, DOI: 10.1016/J.NEURON.2015.05.018 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2026021360A (ja) | 2026-02-10 |
| JP7590962B2 (ja) | 2024-11-27 |
| AU2025242185A1 (en) | 2025-10-30 |
| WO2020097121A1 (en) | 2020-05-14 |
| JP2025024092A (ja) | 2025-02-19 |
| US20250236886A1 (en) | 2025-07-24 |
| US20210395780A1 (en) | 2021-12-23 |
| EP3877529A4 (en) | 2023-01-25 |
| AU2019375975A1 (en) | 2021-06-17 |
| CA3118689A1 (en) | 2020-05-14 |
| EP3877529A1 (en) | 2021-09-15 |
| JP7774695B2 (ja) | 2025-11-21 |
| JP2022513426A (ja) | 2022-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019375975B2 (en) | Artificial expression constructs for selectively modulating gene expression in excitatory cortical neurons | |
| CN108753824B (zh) | 用于治疗视网膜营养不良的病毒载体 | |
| KR20210149060A (ko) | Tn7-유사 트랜스포존을 사용한 rna-유도된 dna 통합 | |
| KR102729768B1 (ko) | 트랜스제닉 선택 방법 및 조성물 | |
| KR101982360B1 (ko) | 콤팩트 tale-뉴클레아제의 발생 방법 및 이의 용도 | |
| AU2019279084B2 (en) | Diverse antigen binding domains, novel platforms and other enhancements for cellular therapy | |
| AU2019257708B2 (en) | Expression of human FOXP3 in gene edited T cells | |
| KR20210151916A (ko) | 뒤시엔느 근육 이영양증의 치료를 위한 aav 벡터-매개된 큰 돌연변이 핫스팟의 결실 | |
| AU774643B2 (en) | Compositions and methods for use in recombinational cloning of nucleic acids | |
| CA2763792C (en) | Expression cassettes derived from maize | |
| CN113271955A (zh) | 用于细胞介导的溶瘤病毒疗法的增强的系统 | |
| CN110467679B (zh) | 一种融合蛋白、碱基编辑工具和方法及其应用 | |
| US20040003420A1 (en) | Modified recombinase | |
| KR20220004959A (ko) | 종양, 종양-상주 면역 세포, 및 종양 미세환경을 콜로니화하기 위해 조작된 면역자극성 박테리아 | |
| BRPI0806354A2 (pt) | plantas oleaginosas transgências, sementes, óleos, produtos alimentìcios ou análogos a alimento, produtos alimentìcios medicinais ou análogos alimentìcios medicinais, produtos farmacêuticos, bebidas fórmulas para bebês, suplementos nutricionais, rações para animais domésticos, alimentos para aquacultura, rações animais, produtos de sementes inteiras, produtos de óleos misturados, produtos, subprodutos e subprodutos parcialmente processados | |
| AU2016343979A1 (en) | Delivery of central nervous system targeting polynucleotides | |
| CN109923211A (zh) | Pd-1归巢核酸内切酶变体、组合物及使用方法 | |
| CN116083398B (zh) | 分离的Cas13蛋白及其应用 | |
| CN108431225A (zh) | 细胞基因组的诱导型修饰 | |
| CN111733174B (zh) | 一种分离的核酸分子及其用途 | |
| PT1984512T (pt) | Sistema de expressão génica utilizando excisão-união em insetos | |
| KR20240029020A (ko) | Dna 변형을 위한 crispr-트랜스포손 시스템 | |
| AU2023412590A1 (en) | Fusion and use thereof | |
| CN113260704B (zh) | CYP4V2和RdCVF在制备药物中的用途 | |
| CN116323942A (zh) | 用于基因组编辑的组合物及其使用方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |